Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products.
On March 12, 2015 Precision Biosciences completed their series A funding roundfunding round with $25.6 million in funding from VenBio (lead investor), Fidelity Biosciences, Amgen Ventures, Baxter Ventures, Osage University Partners, The Longevity Fund, and two more undisclosed investors.